The Readiness Estimate & Deployability Index (READI) measures the level of individual deployment readiness among military and civilian nurses to deploy to austere environments during conflicts or natural disasters.  The ...

Transitioning off cancer treatment is a momentous occasion for pediatric patients and their families, but also brings anxiety and fear, suggesting that there are unmet needs/gaps in services provided at the end of treament. ...

The Readiness Estimate & Deployability Index measures the level of individual deployment readiness among military and civilian nursing personnel for operations in austere environments such as conflicts and natural disasters.  ...

Background: Cancer-related fatigue (CRF) is a very distressing symptom reported by oncology patients. Currently, CRF is measured by self-report instruments. Although clinician-administered questionnaires are more sensitive than self-report scales, there is no available clinician-administered instrument that is validated to measure CRF.                             Purpose: This nurse-led, prospective, repeated measures study investigated the reliability and validity of a 7-item Saligan Fatigue Inventory (SalFI), a recently developed, clinician-administered tool to measure CRF.         Methods: Significant correlations between SalFI and other reliable and valid CRF measures (Functional Assessment of Cancer Therapy–Fatigue [FACT-F], revised Piper Fatigue Scale [rPFS]) were explored using Spearman correlation tests. A global correlation matrix to compare correlations among study time points was developed using the Benjamin-Hockberg method. Study subjects were followed at baseline (T1, before primary cancer treatment), one month (T2) and 3 months (T3) after cancer treatment initiation from two study centers. The study was approved by the Institutional Review Boards of both recruitment centers. Results: A total of 60 subjects were enrolled in the study. The SalFI was highly correlated with both FACT-F (rho=0.69, ppp Conclusion: The SalFI is a reliable and valid clinician-administered measure of CRF. Validation studies in other cancer populations, other clinical populations, and in other languages are warranted....